Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer

The company will begin investigating the effectiveness of TCP008 for the highly infectious disease.

Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.

AI is a tool to make drug discovery cheaper, faster, and better — not a replacement for human ingenuity.

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts, alternative solutions to ensure continued access to medications for all Americans, potential long term consequences if these pharmacy closures continue, and more

The digital revolution has brought more efficient ways to reach and touch HCPs.

Filspari is considered the first non-immunosuppressive treatment to significantly slow kidney function decline in adults with IgA nephropathy.